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In most species, the capability of perceiving and using the passage of time in the seconds-
to-minutes range (interval timing) is not only accurate but also scalar: errors in time
estimation are linearly related to the estimated duration. The ubiquity of scalar timing
extends over behavioral, lesion, and pharmacological manipulations. For example, in mam-
mals, dopaminergic drugs induce an immediate, scalar change in the perceived time (clock
pattern), whereas cholinergic drugs induce a gradual, scalar change in perceived time (mem-
ory pattern). How do these properties emerge from unreliable, noisy neurons ﬁring in the
milliseconds range? Neurobiological information relative to the brain circuits involved in
interval timing provide support for an striatal beat frequency (SBF) model, in which time is
coded by the coincidental activation of striatal spiny neurons by cortical neural oscillators.
While biologically plausible, the impracticality of perfect oscillators, or their lack thereof,
questions this mechanism in a brain with noisy neurons. We explored the computational
mechanisms required for the clock andmemory patterns in an SBFmodelwith biophysically
realistic and noisy Morris–Lecar neurons (SBF–ML). Under the assumption that dopamin-
ergic drugs modulate the ﬁring frequency of cortical oscillators, and that cholinergic drugs
modulate the memory representation of the criterion time, we show that our SBF–ML
model can reproduce the pharmacological clock and memory patterns observed in the
literature. Numerical results also indicate that parameter variability (noise) – which is ubiq-
uitous in the formof small ﬂuctuations in the intrinsic frequencies of neural oscillatorswithin
and between trials, and in the errors in recording/retrieving stored information related to
criterion time – seems to be critical for the time-scale invariance of the clock and memory
patterns.
Keywords: interval timing, striatal beat frequency, computer simulations, dopamine, acetylcholine, neural noise,
noise
INTRODUCTION
The capability of perceiving and using the passage of time in the
seconds-to-minutes range (interval timing) is essential for sur-
vival and adaptation, and its impairment leads to severe cognitive
and motor dysfunctions (Gallistel, 1990; Buhusi and Meck, 2005;
Meck et al., 2008). Considerable progress has been made in recent
years toward elucidating the neural bases of time perception in the
seconds-to-minutes range (Mauk and Buonomano, 2004; Buhusi
and Meck, 2005, 2009; Meck et al., 2008). Recent studies point
toward the cortico-striatal circuits as being critical for interval
timing both, in animals (Matell and Meck, 2000; Matell et al.,
2003; Meck, 2006) and humans (Coull et al., 2004, 2011; Stevens
et al., 2007). Other experiments pointed toward an important role
of the parietal lobe in timing behavior (Harrington et al., 1998;
Schubotz et al., 2000; Onoe et al., 2001; Rao et al., 2001). In par-
ticular, Leon and Shadlen (2003) found evidences of a correlation
between the judgment of time and cell-level neural activity in the
lateral intraparietal area of the posterior parietal cortex of mon-
key (Leon and Shadlen, 2003). As Matell and Meck (2004); Leon
and Shadlen (2003) and others highlighted, it is likely that the
interval timing uses multiple mechanisms and time is represented
in many structures in the brain. Moreover, severe deﬁciencies in
reproducing temporal intervals were found in various neuropsy-
chiatric disorders, such as Parkinson’s (Harrington and Haaland,
1991; Malapani et al., 1998, 2002).
In most species interval timing is not only accurate but also
time-scale invariant, or simply scalar, in that the errors in time esti-
mation are linearly related to the estimated duration (Gibbon, 1977;
Gibbon et al., 1984). In other words, interval timing is increasingly
less precise as the interval being timed lengthens (Figure 1A).
When timing a 30-s interval (left panel of Figure 1A), responses
are distributedwith a quasi–Gaussian distribution around the 30-s
target duration. On the other hand, when timing a 90-s inter-
val (right panel of Figure 1A), responses are distributed with a
quasi–Gaussian distribution around the 90-s target duration. The
scalar property is evident in that normalizing the response func-
tions by the target duration and by the maximum response rate
yields superimposition of response functions (middle panel of
Frontiers in Integrative Neuroscience www.frontiersin.org September 2011 | Volume 5 | Article 52 | 1
Oprisan and Buhusi Modeling pharmacology of interval timing
FIGURE 1 | Scalar property. (A) Mean lever-press response rate in
peak-interval experiments with rats trained with a criterion time of 30 s
(left panel), respectively, 90 s (right panel; re-drawn from Matell et al.,
2004). When normalized by maximum response rate and by the criterion
duration on the horizontal scale, response functions for the two criteria
overlap (middle panel). (B) Administration of indirect dopamine agonist
cocaine results in an immediate, scalar (proportional) leftward shift in
response functions.
Figure 1A). The time-scalar invariance property of interval tim-
ing is ubiquitous in many species from invertebrates such as bees
(Boisvert and Sherry, 2006), to many vertebrates, such as ﬁsh (Tal-
ton et al., 1999),birds (Cheng andWestwood,1993), andmammals
such as rats (Dews, 1962), mice (Buhusi et al., 2009) and humans
(Rakitin et al., 1998). Scalar timing is particular to timing in the
seconds-to-minutes range, but not to circadian timing,which is far
more accurate than interval timing, but whose variance increases
very little with the mean of the interval (Gibbon, 1977; Hinton
and Meck, 1997).
The ubiquity of scalar timing extends over behavioral, lesion
(Meck et al., 1987), andpharmacologicalmanipulations of interval
timing (Buhusi and Meck, 2010). For example, acute administra-
tion of cocaine results in a characteristic leftward shift of response
functions (Figure 1B), consistent with the speeding up of an inter-
nal clock (Matell et al., 2004). Most interestingly, at the same dose,
cocaine speeds up timing of a 90-s interval three times more than
when timing a 30-s interval (Figure 1B), suggesting that the effect
of the drug is proportional – scalar – to the timed interval. More-
over,whennormalized in both amplitude and time as inFigure 1A,
the response functions under cocaine (Figure 1B) superimpose,
indicative of the scalar property.
In mammals, manipulations involving dopaminergic (DA)
drugs such as cocaine induce a particular pattern of response –
clock pattern – that is characterized by several features exempliﬁed
by the data presented in Figure 2A (Meck, 1996). Figure 2A shows
the clock pattern obtained during seven sessions of administration
of DA agonists (red dots) or antagonists (black squares), followed
by seven sessions off-drug, in two groups of rats trained to time a
criterion duration of either a 20-s (lower pattern), or 40s (upper
pattern). First, DA drugs produce an immediate, scalar change in
the perceived time when administered either systemically (Maricq
et al., 1981; Maricq and Church, 1983; Meck, 1983, 1996; Matell
and Meck, 1997; Matell et al., 2004), or directly into the anterior
portion of the striatum (Neil and Herndon Jr., 1978); the pat-
tern is often taken to be suggestive of a change in the speed of an
internal clock, and thus is known as a“clock pattern”(Meck, 1996).
For example, an immediate, scalar (proportional), leftward shift in
perceived time (responding earlier in time than under control con-
ditions) is evident following systemic DA agonist administration,
e.g., methamphetamine or cocaine (black squares in Figure 2A,
upper pattern for a 40-s criterion, lower pattern for a 20-s cri-
terion). Similarly, an immediate, proportional, rightward shift in
perceived time (responding later in time than under control condi-
tions) occurs following systemic administration of DA antagonist,
e.g., haloperidol (red circles in Figure 2A). Second, as shown in
Figure 1B, the magnitude of the shift in the temporal response
scales with the timed duration, and the response functions on-
and off-drug overlap when normalized in amplitude and duration
(Figure 1B). Third, upon chronic administration of DA drugs, the
timing functions recalibrate, i.e., they shift back to the values prior
to drug administration, an effect often interpreted as a relearn-
ing of the clock value associated with a particular duration (left
side of the Figure 2A). Fourth, upon discontinuing the drug reg-
imen, the timing functions rebound (in a scalar manner) in the
opposite direction from the initial effects of the drug (Meck, 1983;
right-side of Figure 2A). This rebound effect is a signature of the
clock pattern. Finally, the magnitude of the shift in the temporal
response scales roughly linearly with the dose (Meck, 1996; Matell
and Meck, 1997; Meck et al., 2011), suggesting a tight relationship
between synaptic dopamine levels and clock-speed.
On the other hand, pharmacological manipulations (Meck,
1983, 1996; Meck and Church, 1987a,b) and lesions (Meck et al.,
1987) aimed at the cholinergic (ACh) systems produce gradual,
scalar (proportional) effects on the memory storage, as shown
in data from Figure 3A. Figure 3A shows the memory pattern
obtained during seven sessions of administration of ACh ago-
nists (red dots) or antagonists (black squares), followed by seven
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FIGURE 2 | Clock pattern. (A)The clock pattern of dopaminergic (DA) drugs
(re-drawn from Meck, 1996): two groups of rats were trained off-drug to time
a criterion time of either 40 s (upper pattern) or 20 s (lower pattern); they were
then administered either DA agonists or antagonists for seven sessions,
followed by seven session off-drug. The ﬁrst administration of DA drugs
results in an immediate, dose-dependent shift in timing, leftward (faster
timing) for DA agonists (solid squares, methamphetamine), and rightward
(slower timing) for DA antagonists (solid circles, haloperidol). Under
continuous training with the pre-drug criterion time and despite continuing the
drug administration, the timing functions recalibrate to the pre-drug criterion
time. Upon discontinuing the drug, timing functions immediately rebound in
the opposite direction, then gradually recalibrate to the pre-drug criterion time
(Meck, 1996). Solid triangles indicate numerical simulations with the SBF–ML
model. The insets indicate the response function generated by the SBF–ML
model throughout the clock pattern (indicated by arrows, and by a triangle
symbol of the color of the inset). Insets: A1: immediate rebound fromT=40
toT ∗∗ =48 s upon discontinuing methamphetamine; A2: recalibration under
methamphetamine; A3: immediate shift under methamphetamine from
T=40 toT ∗ =32 s; A4: immediate shift under haloperidol fromT=20 to
T ∗=24 s; A5: recalibration under haloperidol; A6: immediate rebound upon
discontinuing haloperidol. The dashed (A1–3), respectively, continuous (A4–6)
smooth lines represent Gaussian ﬁts. (B). The Gaussian ﬁts (dashed smooth
lines) in (A1–3) are given by Gauss (48, 31 s), Gauss (40, 27 s), respectively,
Gauss (32, 21 s). Timing functions at different points of the clock pattern for
T=40 s are time-scale invariant. (C). Timing functions from the 20-s clock
pattern and 40-s clock pattern are time-scale invariant. (D). The Gaussian ﬁts
(continuous smooth lines) in (A4–6) are given by Gauss (24, 16 s), Gauss (20,
13 s), respectively, Gauss (16, 11 s). Timing functions at different points of the
clock pattern forT=20 s are time-scale invariant. Colors match the insets. All
Gaussian ﬁts of numerical simulations gave COD>0.9 and p <0.0001.
sessions off-drug, in two groups of rats trained to time a criterion
duration of either a 20-s (lower pattern) or 40-s (upper pattern):
ﬁrst, administration of ACh drugs produced a gradual (rather than
immediate), scalar temporal shift (Meck, 1996); ACh lesions pro-
duce permanent effects (Malapani and Fairhurst, 2002). Second,
chronic administration ampliﬁes (rather than recalibrates) the
temporal shift (left side of Figure 3A). Third, upon discontinu-
ing the drug administration, the timing functions gradually return
to the original criterion time (Figure 3A, right-side). Finally, the
magnitude of the shift in the temporal response scales with the
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FIGURE 3 | Memory pattern. (A)The memory pattern of cholinergic (ACh)
drugs (re-drawn from Meck, 1996): two groups of rats were trained off-drug to
time a criterion time of either 40 s (upper pattern) or 20 s (lower pattern); they
were then administered either ACh agonists or antagonists for seven
sessions, followed by seven session off-drug. The ﬁrst administration of ACh
drugs results in a minimal effect; repeated ACh drug administration results in
a gradual, dose-dependent shift in timing, leftward for ACh agonists (solid
circles, physostigmine), and rightward for ACh antagonists (solid squares,
atropine). Upon discontinuing the drug, timing functions gradually recalibrate
to the initial criterion time (Meck, 1996). Solid triangles indicate numerical
simulations obtained with the SBF–ML model. The insets indicate the output
function generated by the SBF–ML model with biophysically realistic ML
neurons throughout the memory pattern (indicated by arrows, and by a
triangle symbol of the color of the inset). Insets: A1: gradual shift fromT=40
toT ∗ =50 s under atropine; A2: gradual recalibration upon discontinuing
atropine; A3: gradual recalibration upon discontinuing physostigmine; A4:
gradual recalibration under physostigmine. The dashed (A1,2), respectively,
continuous (A3,4) smooth lines represent Gaussian ﬁts. (B). The Gaussian ﬁts
(dashed smooth lines) in (A1,2) are given by Gauss (50, 33 s), respectively,
Gauss (40, 27 s). Timing functions at different points of the memory pattern
forT=40 s are time-scale invariant. (C). Timing functions from the 20-s
memory pattern and 40-s memory pattern are time-scale invariant. (D). The
Gaussian ﬁts (continuous smooth lines) in (A3,4) are given by Gauss (20,
13 s), respectively, Gauss (15, 10 s). Timing functions at different points of the
memory pattern forT=20 s are time-scale invariant. Colors match the insets.
All Gaussian ﬁts of numerical simulations gave COD>0.9 and p <0.0001.
timed duration (Meck, 1996), twice as large for the 40-s group
(upperpattern inFigure 3A) than for the 20-s group (lowerpattern
in Figure 3A). The memory pattern is consistent with alterations
of the internal representation of the memorized criterion time
(Meck, 1996).
How do the pharmacological properties of timing in the
seconds-to-minutes range, including the scalar effect of dopamin-
ergic (DA) and cholinergic (ACh) drugs, emerge from unreliable,
noisy neurons ﬁring in the milliseconds range? A response to these
questions was recently proposed by a neurobiologically inspired
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computationalmodel of interval timing: the striatal beat frequency
(SBF) model (Matell and Meck, 2000, 2004; Buhusi and Meck,
2005; Figure 4). The model is based on the idea that striatal spiny
neurons integrate the activity of massive ensembles of cortical
oscillators to produce coincidental beats that have periods span-
ning a much wider range of durations than the intrinsic periods of
the cortical oscillators (Miall, 1989;Matell andMeck, 2004; Buhusi
and Meck, 2005). Our implementation of the SBF–Morris–Lecar
(ML) model closely follows Matell and Meck (2004) with three
main changes: (1) we replaced the sinewavemathematical abstrac-
tionof oscillatorswithbiophysically realistic andnoisyML(Morris
and Lecar, 1981; Rinzel and Ermentrout, 1998) model neurons,
and (2) we implemented neuromodulatory circuits that mimic the
DA and ACh systems, and (3) we implemented the equivalent of
trials and sessions, to address the effect of experimental DA, ACh,
and lesion manipulations (Figure 4). Our SBF–ML implementa-
tion contains a time-base provided by a large number of neural
oscillators presumably localized in the frontal cortex (FC; Matell
et al., 2003). Following Matell and Meck (2004) review of the neu-
roanatomical foundations of the SBF model, among many other
ﬁring patterns observed in FC, the synchronized cortical oscilla-
tions in the 8- to 13-Hz range (alpha) could serve as pacemakers
for temporal accumulation (Anliker, 1963). Furthermore, Rizzuto
et al. (2003) have shown that alpha range oscillations in humans
reset upon occurrence of to-be-remembered or probe stimuli, sug-
gesting that the phase of these rhythms may be of importance in
interval timing. The set of synaptic weights between neural oscil-
lators in the FC and the spiny neurons in the striatum, which
is the input to the basal ganglia (BG), represent a (long-term)
memory buffer. Learning of the criteria times also depends on
nucleus basalis magnocellularis (Meck et al., 1987), FC (Olton
et al., 1988), and the hippocampus (Meck et al., 1987; Olton et al.,
1988).A coincidence detectorwas implemented tomimic the spiny
FIGURE 4 |The striatal beat frequency model. Schematic representation
of the neurobiological structures involved in interval timing in the SBF
model. Dashed lines signify couplings that are not implemented in our SBF
version. Frontal oscillators are implemented as biophysically realistic ML
neurons. ACh, acetylcholine; FC, frontal cortex; BG, basal ganglia; DA,
dopamine; Glu, glutamate; GPE, globus pallidus external; GPI, globus
pallidus internal; STn, subthalamic nucleus; SNc/r, substantia nigra pars
compacta/reticulata; TH, thalamus; VTA, ventral tegmental area.
neurons in the striatum, which integrate a very large number of
different inputs, and responds selectively to particular reinforced
patterns (Houk, 1995; Houk et al., 1995; Beiser and Houk, 1998).
As opposed to the existing implementations of the SBF model
(Miall, 1989; Matell and Meck, 2004; Buhusi and Meck, 2005), a
neuromodulatory circuit that mimics “a start gun” in regard to
the effect of DA projections from substantia nigra pars compacta
(SNc), a neuromodulatory circuit that models the DA projections
from the ventral tegmental area (VTA) to the FC, and a cholinergic
system which modulates the BG activity were also implemented in
our SBF–ML model (Figure 4).
While “biologically plausible,” the impracticality (or lack
thereof) of perfect oscillators questions the robustness of an SBF
model in a brain with real, noisy neurons, particularly after phar-
macological manipulations. Here we explore the neural mech-
anisms required for clock (Figure 2), and memory (Figure 3)
patterns in an SBF–ML model. First, we checked numerically that,
in the limit of a very large number of neural oscillators and in the
presence of noise, the output of an SBF–MLmodel is Gaussian-like
(Figure 5). Second, under the assumption that DA drugs modu-
late the ﬁring frequency of cortical oscillators, and that ACh drugs
modulate the memory representation of the criterion time, we
show that the SBF–ML model reproduces the pharmacological
clock (Figure 2), and memory (Figure 3) patterns observed in
the literature. Third, our numerical results support the conjecture
(Matell andMeck, 2004) that parameter variability (noise) –which
is ubiquitous in the form of small ﬂuctuations in the intrinsic fre-
quencies of the neural oscillators within and between trails, and
in the errors in recording/retrieving stored information related to
criterion time – is critical for the time-scale invariance of the clock
and memory patterns of interval timing.
MATERIALS AND METHODS
NUMERICAL SIMULATIONS ASSUME BIOPHYSICALLY REALISTIC
MORRIS–LECAR NEURONS.
Since action potential recordings from real neurons are never
phase oscillators, i.e., sine waves, we departed from cortical phase
oscillators (Matell and Meck, 2004) and we instead implemented
biophysically realistic ML cortical neurons (Morris and Lecar,
1981; Rinzel and Ermentrout, 1998). The membrane potential of
the ML model neuron is given by CmV′ = Ibias − ICa − IK − IL,
where Cm is the membrane capacitance, prime denotes the deriv-
ative of the membrane potential V, Ibias is a constant bias cur-
rent required to bring the model to the excitability threshold,
ICa = gCam(V − ECa) is the calcium current that involves the
conductance gCa, the fraction m of calcium channels open at
a given V, and the reversal potential ECa for calcium channels,
IK = gKn(V − EK) is the potassium current that involves the con-
ductance gK, the fraction n of channels open at a given V, and the
reversal potential EK for potassium channels, IL = g L(V − EL) is
a leak current that only involves a conductance g L and a reversal
potential EL. (Morris and Lecar, 1981; Rinzel and Ermentrout,
1998).
THE SBF–ML MODEL
Brieﬂy, a set of N osc = 600 neural oscillators with uniformly dis-
tributed intrinsic frequencies fi was assumed to activate through
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FIGURE 5 | Scalar property in an SBF–ML model is dependent on noise.
(A) Numerical simulations of an SBF–ML model with Gaussian variability of
the criterion time and between-trial variability in frequencies of cortical
neurons generated response functions (jagged traces) with Gaussian-like
envelopes (smooth curves). The dashed (continuous) envelope corresponds to
30 s (90 s) criterion time. (B) In the presence of noise, the variance of output
function is proportional with the criterion time, thus indicating time-scale
invariance (ﬁlled squares). The coefﬁcient of correlation for the linear
regression (continuous line) was r =0.9 with a p-value less than 0.001. In the
absence of the noise, the variance of the output function is constant (ﬁlled
circles), thus violating the time-scale invariance. The coefﬁcient of correlation
for the linear regression (dashed line) was r =0.98 with a p-value less than
0.0001. (C) Numerical simulations of an SBF–ML model with normally
distributed variability for both the criterion time and both within- and
between-trials variability in frequencies generate response functions (jagged
traces) with Gaussian-like envelopes (smooth curves). The only noticeable
difference when adding within-trial frequency variability is the occurrence of
the skewness in the response rate at late times. A similar skewness was
observed in the behavioral data (see Figure 1) (D)The Gaussian envelopes for
the case of criterion time variability (A) are given by Gauss (30, 21 s),
respectively, Gauss (90, 60 s). They overlap when normalized in amplitude and
in time.
synapticweightsw ij(t ) a set of Nmem = 1000 spiny neurons at time
t (Figure 4; our choice of N osc andNmem was due to limitations on
simulation duration, about 5 days on an HP Blade computer). The
membrane potential of neural oscillators was normalized from
[−80, +40mV] to [−1,1] by a linear transformation that pre-
serves the shape of the action potential (Rinzel and Ermentrout,
1998). Themodeled experimental setting included both reinforced
and non-reinforced trials. At the onset of each trial, the oscillators
were reset (0 phase), then neurons were set to ﬁre with frequen-
cies fi, set during each trial, but variable from trial to trial. During
reinforced trials, upon delivery of the reinforcement at criterion
time T, a linear combination of oscillators’membrane potential in
the current trial at the criterion time T was stored in long-term
memory as criterion patternw ij(T ) (Matell andMeck, 2004). Dur-
ing non-reinforced (test) trials, spiny neurons were assumed to act
as coincidence detectors by computing the projection (dot prod-
uct) of the running weights w ij(t ) stored in the working memory
onto the retrieved reference weightswij(T ) stored in the long-term
memory:
output(t ) =
trials∑
k=1
Nosc∑
i=1
Nmem∑
j=1
wij(t )wij(T ).
We assumed that both the storage and retrieval of the cri-
terion time [stored as criterion pattern w ij(T )] to and from
long-term memory is affected by random biological noise, mod-
eled as follows: criterion time variabilitywasmodeled by randomly
distributing the criterion time T according to a normal density
probability function pdfT with 0.4T variance. This assumption
accounts for the randomness in learned sample times (reinforced
times) and in response time; e.g., in a peak-interval procedure
(Gibbon et al., 1984) animals are reinforced for the ﬁrst response
after a criterion time, but since the animal’s response is random,
the reinforced time is random, though close in time to the cri-
terion. Therefore, sample times stored in memory were assumed
to be distributed around T. Additional randomness was included
in our SBF–ML implementation by a Gaussian noise added to the
intrinsic frequencies fi of the neural oscillators within and between
trails. The within-trial variability in frequencies fi accounts for the
randomness in response (e.g., for the ﬁrst response reinforced),
while the between-trial variability accounts for the observed dif-
ferences in response between-trials (Church et al., 1994; Swearin-
gen and Buhusi, 2010). Another reason to differentiate between
within- and between-trial variability in frequencies fi has to do
with our focus on pharmacological manipulations, which exper-
imentally are conducted in on- and off-drug sessions. Because
we assumed that DA drugs change the frequencies fi, this implies
differences in coding and decoding of criterion time in on- and
off-drug sessions (trials). This in turn implies variations in both
the encoding and the recall of the criterion time due to the current
(on- or off-drug) frequencies fi.
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THE CLOCK PATTERN OF DOPAMINERGIC DRUGS
Weassumed that phasic release of dopamine fromVTA toFCmod-
ulates the ﬁring rate of FC neural oscillators, and that DA drugs
affect the frequency of the cortical oscillators, f ∗i = (1 + α)fi ,
where α accounts for the action of the drug and its magnitude
is dose-dependent, with 0< α< 1 for dopamine agonists, such
as methamphetamine or cocaine, and −1< α< 0 for dopamine
antagonists, such as haloperidol. Simulations in Figure 2 were car-
ried out with an SBF–ML model using N osc = 600 biophysically
realistic ML cortical neurons ﬁring in the range [8, 12]Hz, using
Nmem = 1000memory samples,with adrugdose effectα=± 0.25.
RELEARNING OF THE CRITERION TIME ON-DRUG, AND OFF-DRUG
Meck (1996) suggested that the recalibration of the clock pat-
tern may be due to relearning of the criterion time T under the
drug. Numerically, we assumed that the criterion time is stored
in long-term memory as a distribution of Nmem = 1000 samples,
and that in each session, a fraction (25%) of the weights w ij(T ) are
updated, by storing the new pattern of the FC oscillators (off-drug
or on-drug) upon delivery of reinforcement at criterion time T.
We ran four sessions of 250 trials off-drug to acquire the distribu-
tion w ij(T ) with the off-drug frequency set fi which vary from trial
to trial. For each trial, a sample w ij(T ) was computed as a linear
combination of the membrane potential at the criterion time T
(Matell and Meck, 2004). During drug sessions, a fraction (25%)
of the weights w ij(T ) originally stored off-drug, are replaced with
new running weights w(T ∗), stored on-drug, such that gradually
the weights w stored in the reference (long-term) memory are
characteristic of the on-drug state. Similarly, when discontinuing
the drug, we assumed that the criterion time, stored in long-term
memory as a distribution of w(T ∗) samples, stored on-drug, is
replaced with a fraction (25%) during each off-drug session, such
that with sufﬁcient training, the weights w stored in the reference
(long-term) memory will be characteristic of the off-drug state.
THE MEMORY PATTERN OF CHOLINERGIC DRUGS
Our numerical implementation assumes that administration of
ACh drugs alters the re-coding of the criterion time in long-term
memory (Meck,1996;Matell andMeck,2004). Brieﬂy,we assumed
that criterion time T is coded in long-term memory as a distribu-
tion of Nmem = 1000 samples w(T ), and that ACh drugs alter the
process involved in memorizing this distribution, with about 25%
samples learned in each session. The new samples are assumed to
represent an altered, on-drug representation of the criterion time,
T ∗ = k∗T, where the multiplicative coefﬁcient k∗ is both drug and
dose-dependent (Gibbon et al., 1984; Meck, 1996). At the begin-
ning of the drug administration, only a small subpopulation of the
memory samples is affected; with continuing training on-drug,
these altered samples make up the majority of the memory sam-
ples and lead to a progressive shift of the peak output to T ∗. For
simulations presented in Figure 3 we assumed k∗ = 1.25 for ACh
antagonist atropine, and k∗ = 0.75 forACh agonist physostigmine.
STATISTICAL ANALYSES
Throughout this paper, the Origin package (OriginLab Co.,
Northampton,MA,USA) was used to perform data ﬁts to smooth
analytic curves, and to compare the degree of superposition
between curves. The degree of superposition of curveswas indexed
by a coefﬁcient of determination (COD) and the probability (p)
to obtain a certain COD value by chance was estimated. Brieﬂy,
the COD measures the proportion of the total variation in the
dependent variable that is explained by the regression equation (ﬁt
function),with 0<COD< 1 (Brockwell andDavis, 1991; Resnick,
2006). The correlation described by the COD is usually considered
“good” if the COD> 0.7 (Nagelkerke, 1991; Cameron and Wind-
meijer,1997;Anderson et al., 2009). If the regression curve is linear,
then the COD reduces to the correlation coefﬁcient (r).
RESULTS
THE SBF–ML EXHIBITS TIME-SCALE INVARIANCE
Previous studies indicated that in the absence of biological noise,
an SBF model with cortical phase oscillators (sine waves) does not
exhibit time-scale invariance (Matell and Meck, 2004). We found
a similar behavior of our implementation of the SBF–ML model.
In the presence of normally distributed variability in the criterion
time, and between-trial variability in the frequencies of cortical
neurons, the output functions were Gaussian-like (Figure 5A)
and exhibited more variance when increasing the criterion dura-
tion T (ﬁlled squares in Figure 5B). On the other hand, in the
absence of biological noise the SBF–ML model produces an out-
put function whose envelope is almost Gaussian but violates the
scalar property (ﬁlled circles in Figure 5B).Moreover,when adding
normally distributed within-trial frequency variability on top of
the existing between-trial frequency variability, and variability in
criterion time, the output functions were still Gaussian-like with
SD proportional to the criterion time (Figure 5C). Moreover, in
the presence of these three sources of variability (Figure 5C) the
output function has a long tail that does not decrease to zero as
fast as the smooth Gaussian ﬁt. Such a skewed and long-tailed
Gaussian-like output function was observed in behavioral exper-
iments (see Figure 1). When normalized in amplitude and over
time, the envelopes of the response functions from Figure 5C
overlap (Figure 5D). These ﬁndings support the conjecture made
byMatell andMeck (2004) that in an SBFmodel at least one source
of variability is required in order to observe time-scale invariance.
Therefore, biological noise – which is ubiquitous in the form of
small ﬂuctuations of the intrinsic within- and between-trial fre-
quencies of the neural oscillators, errors in recording/retrieving
stored information related to criterion time – seems to be a rather
critical component of this feature of the SBF–MLmodel. However,
considering the focus of our paper on pharmacological manipu-
lations, for numerical efﬁciency reasons and without reducing the
generality of our results, in the following analyzes we only used
two sources of variability (noise) when numerically integrating
the equations of the SBF–ML model: normally distributed vari-
ability in the criterion time, and between-trial variability in the
frequencies of cortical neurons.
THE CLOCK PATTERN OF DOPAMINERGIC DRUGS IN THE SBF–ML
MODEL
Immediate shift upon changes in drug state
The clock effect of DA drugs can be easily understood as an
interplay between the storage and retrieval of the criterion time
representation w ij(T ) on- and off-drug. A change in drug state
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induced an immediate change in oscillator frequencies from the
off-drug frequencies f to the on-drug frequencies f∗, respectively,
from the on-drug frequencies f∗ to the off-drug frequencies f. In
our numerical implementation of the SBF–ML, the neural oscil-
lators ﬁre off-drug in the frequency range [fmin, fmax] and that the
criterion timeT is represented off-drug as a set of synaptic weights
w ij(T ). The DA drugs alter the frequency of the cortical oscillators
to f ∗i = (1 + α)fi such that the on-drug frequency range changes
to [f ∗min, f ∗max]. As a result, the projection (coincidence detection)
of the vector of the current on-drug weights w∗ij (t ) to the vector of
reference off-drug weights w ij(T ) peaks at a time T ∗ that differs
from T.
Numerical simulations indicate that our implementation of
the SBF–ML model shows the major features of the clock pattern
effect: immediate, scalar shift in timing, and recalibration on-drug,
followed by an immediate, scalar rebound, and recalibration off-
drug (solid triangles in Figure 2A). Simulations carried with α> 0
for dopamine agonists, indicate an immediate, leftward shift of the
response function toT ∗ <T (inset A3 in Figure 2A), in agreement
with experimental data for DA agonists methamphetamine, and
cocaine (Meck, 1996; Buhusi and Meck, 2002; Matell et al., 2004).
On the other hand, forα< 0we replicated numerically an immedi-
ate rightward shift due to a slow down of cortical oscillators during
retrievalT ∗ >T (inset A4 in Figure 2A), in agreement with exper-
imental observation of the effect of DA antagonist haloperidol
(Meck, 1996; Buhusi and Meck, 2005).
Recalibration upon chronic drug administration
According to the clock pattern (Meck, 1996), chronic drug admin-
istration results in a gradual recalibration, such that the response
time on-drug gradually approaches the response time off-drug
drug, an effect which is not due to receptor desensitization, but
rather attributed to relearning of the criterion time using the drug-
altered cortical frequencies (Meck, 1996). In our implementation,
the repeated drug administration results in the criterion time T –
which is represented in memory by a distribution of learned pat-
terns wij(T ) – to be gradually re-written with new samples of rein-
forced duration, samples which are computed using drug-altered
oscillator frequencies. We found that our SBF–ML model exhibits
recalibration of the criterion time T ∗ back to T under repeated
methamphetamine administration (α> 0, inset A2 of Figure 2A)
as well as under repeated haloperidol administration (α< 0, inset
A5 of Figure 2A). A similar recalibration occurs after the drug is
discontinued, when the model re-learns the weights w ij(T ) for the
criterionT off-drug (see right-side of Figure 2A). Interestingly, the
rates of the two recalibration processes (Figure 2A) to the original
criterion time T are not necessarily identical since the presence
of the drugs may also signiﬁcantly change the rate at which the
memory is overwritten. In order to match pharmacological data
from (Meck, 1996; Buhusi and Meck, 2002; Matell et al., 2004), we
set the overwrite rate at 25% samples per session (Figure 2A).
Immediate rebound in the opposite direction, upon discontinuing
the drug
In the SBF–ML model, discontinuing the drug results in a scalar
rebound of the response in the opposite direction, due to the sud-
den change from on-drug cortical frequencies f∗ to the off-drug
cortical frequencies f = (1− β)f∗. For example, an immediate left-
ward shift from T = 40 s (inset A2 in Figure 2A) to T ∗ = 32 s
(inset A3 in Figure 2A) under methamphetamine is followed by
relearning of the criterion on-drug; discontinuing the drug results
in an immediate rightward displacement to T ∗∗ = 48 s (inset A1
in Figure 2A), followed again by a slow recalibration back to the
original criterion time T= 40 s due to relearning of the criterion
time with the new cortical frequencies.
Time-scale invariance of the clock-speed effect
For our implementation of the SBF–ML model, the preservation
of time-scale invariance throughout the clock pattern is shown
in the lower panels of Figure 2. For example, the amplitude of
the immediate shift in response time at the transition between the
off-drug to the on-drug state, and the amplitude of the immedi-
ate, opposite rebound at the transition between the on-drug to
the off-drug state, are proportional to the criterion interval T (see
Figure 2B for T = 40 s and Figure 2D for T = 20 s). Moreover, the
variance in the response rate (width of response/output function),
throughout the pharmacological manipulation remains propor-
tional to the current response time, either off-drug T, or off-drug
T ∗ (Figures 2B and 2D). For the 40-s criterion,Figure 2B indicates
that the envelopes of response functions in the insets A1, A2, and
A3 of Figure 2A superimpose when renormalized in amplitude
and time. Similarly, for the 20 s criterion time, Figure 2D indi-
cates that the envelopes of response functions in the insets A4, A5,
and A6 of Figure 2A superimpose when normalized in amplitude
and time. Finally, the scalar property is preserved also between
different criterion times: Figure 2C indicates that the envelopes
of the response functions from inset A2 of Figure 2A (T ∗∗ = 40 s
recalibrated under methamphetamine) and inset A5 of Figure 2A
(T ∗∗ = 20 s recalibrated under haloperidol) superimposed when
normalized in amplitude and in time.
THE MEMORY PATTERN OF CHOLINERGIC DRUGS IN THE SBF–ML
MODEL
Previous research indicates that the administration of ACh agonist
physostigmine results in a gradual, dose-dependent leftward shift
of the response (solid circles in Figure 3A; Meck, 1996). Similarly,
administration of ACh blocker atropine leads to a gradual and
dose-dependent rightward shift of the psychophysical functions
(solid squares in Figure 3A; Meck, 1996). Moreover, the mag-
nitudes of the temporal shifts observed are dose-dependent and
proportional to the intervals being timed (Meck, 1996). To address
this issue, it was proposed that training under the inﬂuence of the
ACh drug produces a gradually re-learning of an altered criterion
timeT ∗ = k∗T (Gibbon et al., 1984;Meck, 1996; Buhusi andMeck,
2010).
In the SBF–ML model, the dynamics of memory pattern
(Figure 3A) is signiﬁcantly different from that of the clock pat-
tern (Figure 2A): while the clock pattern takes effect as soon as
the frequencies of neural oscillators are changed by the drug, thus
producing an immediate temporal shift because of the sudden
mismatch in cortical frequencies during storage, and retrieval, the
memory pattern is determined by a gradual alteration of represen-
tation of the criterion time in the long-term memory that affects a
growing number of memorized sample weights. Relearning the
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criterion under the ACh drug eventually overwrites the entire
long-term memory with the altered representation k∗T of the
criterion time T. This induces a gradual change in the content
of the long-term memory that leads to an increasing mismatch
between the contents of the working and the long-term memory
(Figure 3A).
In our numerical implementation, for ACh agonist atropine,
we assumed k∗ = 1.25 in order to match the pharmacological data
from Meck (1996). As shown in Figure 3A (solid triangles), the
gradual change inmemory samples under atropine gradually shifts
the peak of the output function from the initial value, T = 20 s
(inset A3 in Figure 3A), to the altered valueT ∗ = k∗T= 15 s (inset
A4 in Figure 3A). A similar shift takes place for ACh antagonists,
say from T = 40 s (inset A2 in Figure 3A) to T ∗ = 50 s (inset A1
in Figure 3A). Most importantly, both the amplitude of the grad-
ual shift on-drug and the amplitude of the recalibration when
the ACh drug is discontinued are proportional to the criterion
interval T (Figure 3A). Moreover, the variance (width) of the
response remains scalar, i.e., proportional to the current peak time,
either off-drug, T, or on-drug, T ∗ (Figure 3B for T = 40 s and
Figure 3D for T = 20 s). For the 40-s criterion time, Figure 3B
indicates that the envelopes of response functions in the insets A1
and A2 of Figure 3A superimpose when normalized in amplitude
and time. Similarly, for the 20-s criterion, Figure 3D indicates that
the envelopes of response functions in the insets A3 and A4 of
Figure 3A superimpose when normalized in amplitude and time.
Finally, the scalar property is preserved also between different cri-
terion times:Figure 3C indicates that the envelopes of the response
functions from inset A2 of Figure 3A (T= 40 s, dashed line) and
inset A3 of Figure 3A (T = 20 s, solid line) superimposed when
normalized in amplitude and time.
DISCUSSION
In mammals, DA drugs induce an immediate, scalar change in
the perceived time (clock pattern, Figure 2), whereas ACh drugs
induce a gradual change in perceived time (memory pattern,
Figure 3). To explain these patterns, we assumed that DA drugs
induce a sudden change in the speed of an internal clock, while
ACh drugs induce a gradual change in the memory of the criterion
duration (Gibbonet al.,1984;Meck,1996).Most importantly,both
the clock and memory patterns are scalar, i.e., the drug effects are
proportional to the criterion duration (Gibbon et al., 1984; Meck,
1996).
Current neurobiological data supports a SBF model, in which
time is coded by the coincidental activation of striatal spiny neu-
rons by cortical neural oscillators (Matell and Meck, 2000, 2004;
Buhusi and Meck, 2005). While generally biologically plausible,
the impracticality of perfect oscillators (or the lack thereof), ques-
tions the robustness of such a mechanisms in a brain with real,
noisy neurons, particularly after pharmacological manipulations.
Here we explored the neural mechanisms required for the time-
scale invariance of the clock (Figure 2) and memory (Figure 3)
patterns produced by the SBF–ML model (Figure 4). To our
knowledge, this is the ﬁrst time the SBF-type model was used to
match pharmacological data, and the ﬁrst time it is implemented
using biophysically realistic neurons instead of simple sine waves.
This combination of features opens the possibility of calibrating
the timing network by adjusting conductances and half-activation
voltages for speciﬁc ionic channels to mimic the effect of different
drugs at channel-level.
Under the assumption that the biological noise is ubiquitous
in the form of, e.g., variability of frequency within- and between-
trails, variability in memory storage, and retrieval, etc., numerical
simulations indicated that the SBF–ML model shows the scalar
property, i.e., errors in time estimation are linearly related to the
estimatedduration (ﬁlled squares inFigure 5B). Interestingly, sim-
ply replacing crisp cortical phase oscillators with crisp cortical ML
neurons did not produce scalar effects (ﬁlled circles in Figure 5B).
It was onlywhen at least one source of variability (noise)was intro-
duced that the scalar property was evident. This result supports
and extends the conjecture of Matell and Meck (2004) by which
the SBF model requires at least one source of variance (noise) to
address time-scale invariance.
Computational models of interval timing vary largely with
respect to the hypothesized mechanisms by which temporal pro-
cessing is explained, and by which time-scale invariance, or drug
effects are explained. The putative mechanisms of timing rely on
pacemaker/accumulator processes (Gibbon, 1977; Gibbon et al.,
1984), sequences of behaviors (Killeen and Fetterman, 1988), pure
sine oscillators (Church and Broadbent, 1990; Matell and Meck,
2000, 2004), memory traces (Grossberg and Schmajuk, 1989;
Grossberg and Merrill, 1992; Machado, 1997; Buhusi and Schma-
juk, 1999; Staddon and Higa, 1999), or cell and network-level
models (Leon and Shadlen, 2003; Simen et al., 2011). For example,
both neurometric functions from single neurons and ensemble of
neurons successfully paralleled the psychometric functions for the
to-be-timed intervals shorter than 1 s (Leon and Shadlen, 2003).
Reutimann et al. (2004) also considered interacting populations
that are subject to neuronal adaptation and synaptic plasticity
based on the general principle of ﬁring rate modulation in single-
cell. Balancing LTP and LTD mechanisms are thought to modulate
the ﬁring rate of neural populations with the net effect that the
adaptation leads to a linear decay of the ﬁring rate in time. There-
fore, the linear relationship between time and the number of
clock ticks of the pacemaker–accumulator model in the scalar
expectancy theory of interval timing (Gibbon, 1977) was success-
fully translated into a linearly decaying ﬁring ratemodel thatmaps
time and variable ﬁring rate. As Matell and Meck (2004) stated, it
may be that the brain uses both (relatively) stable neural oscillators
in an SBF-based paradigm and a variable ﬁring rate paradigm for
interval timing.
Dopaminergic drugsmodulation of the ﬁring frequency of cor-
tical oscillators led in our numerical simulations of the SBF–ML
model to clock patterns (Meck, 1996): immediate change in tim-
ing (inset A3 of Figure 2A) and gradual re-calibration under the
drug (inset A2 of Figure 2A), immediate re-bound in the oppo-
site direction (inset A1 of Figure 2A) and gradual re-calibration
upon discontinuing the drug, and scalar (proportional) effects
(Figures 2B–D). ACh drugs modulation of the representation
w ij(T ) of the criterion time in the long-term memory led in
our numerical simulations of the SBF–ML model to memory
patterns (Meck, 1996): gradual change in timing on-drug (inset
A1 of Figure 3A), gradual re-calibration upon discontinuing the
drug (inset A3 of Figure 3A), and scalar (proportional) effects
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(Figures 3B–D). Our interpretation of the clock and memory
patterns within the SBF model is in accord with the interpreta-
tion of drug effect in the scalar expectancy theory (SET; Gibbon,
1977; Gibbon et al., 1984). As in SET, our numerical simulations
assume that DA drugs alter the time-base of the model, and that
ACh drugs alter memory processes. In recognition of this legacy,
our description of the ACh memory effects continue to use the
(rather famous) k∗ factor (Gibbon et al., 1984; Meck, 1996).
In summary, numerical simulations with the SBF–ML model
successfully reproduced the clock (Figure 2) and memory
(Figure 3) effects reported in the literature (Meck,1996), including
their scalar effects (Gibbon, 1977;Gibbon et al., 1984;Meck, 1996),
previously addressed only by a few established behavioral models
in the ﬁeld, such as SET (Gibbon, 1977; Gibbon et al., 1984), and
STM (Grossberg and Schmajuk, 1989). Together with previous
studies (Matell and Meck, 2000, 2004; Buhusi and Meck, 2005),
the current results establish the SBF model as a neurobiologically
realistic model of interval timing capable of explaining a large
range of phenomena, from behavior, to lesions, and pharmacol-
ogy, with the potential to provide insight into the neurobiological
bases on interval timing.
ACKNOWLEDGMENTS
This research was supported the National Science Foundation
CAREER award IOS 1054914 to Sorinel A. Oprisan. Catalin V.
Buhusi was supported by the National Institutes of Health grants
MH65561 and MH73057. We are also indebted to Warren H.
Meck and Matthew S. Matell for helpful discussions about the
SBF model, and to Joshua Swearingen for helpful comment on an
early version of the manuscript.
REFERENCES
Anderson, D. R., Sweeney, D. J., and
Williams, T. A. (2009). Essentials of
Statistics for Business and Econom-
ics. Mason, OH: Thomson Higher
Education.
Anliker, J. (1963). Variations in alpha
voltage of the electroencephalogram
and time perception. Science 140,
1307–1309.
Beiser, D. G., and Houk, J. C. (1998).
Model of cortical-basal ganglionic
processing: encoding the serial order
of sensory events. Clin. Neurophys-
iol. 79, 3168–3188.
Boisvert, M. J. M. J., and Sherry, D.
F. D. F. (2006). Interval timing by
an invertebrate, the bumble bee
Bombus impatiens. Curr. biol. 16,
1636–1640.
Brockwell, P. J., and Davis, R. A. (1991).
Time Series: Theory and Models, 2nd
Edn. New York: Springer.
Buhusi, C. V., Aziz, D., Winslow, D.,
Carter, R. E., Swearingen, J. E., and
Buhusi, M. C. (2009). Interval tim-
ing accuracy and scalar timing in
C57BL/6 mice. Behav. Neurosci. 123,
1102–1113.
Buhusi, C. V., and Meck, W. H. (2002).
Differential effects of methampheta-
mine and haloperidol on the control
of an internal clock. Behav. Neurosci.
116, 291–297.
Buhusi, C. V., and Meck, W. H. (2005).
What makes us tick? Functional and
neural mechanisms of interval tim-
ing. Nat. Rev. Neurosci. 6, 755–765.
Buhusi, C. V., and Meck, W. H. (2009).
Relative time sharing: new ﬁndings
and an extension of the resource
allocation model of temporal pro-
cessing. Philos. Trans. R. Soc. Lond.
B Biol. Sci. 364, 1875–1885.
Buhusi, C. V., and Meck, W. H.
(2010). “Timing behavior,” in Ency-
clopedia of Psychopharmacology, ed.
I. P. Stolerman (Berlin: Springer),
1319–1323.
Buhusi, C. V., and Schmajuk, N. A.
(1999). Timing in simple condition-
ing and occasion setting: a neural
network approach. Behav. Process.
45, 33–57.
Cameron, A. C., and Windmeijer, F. A.
G. (1997). An R-squared measure
of goodness of ﬁt for some com-
mon nonlinear regression models. J.
Econom. 77, 329–342.
Cheng, K., and Westwood, R. (1993).
Analysis of single trials in pigeons’
timing performance. J. Exp. Psy-
chol. Anim. Behav. Process. 19,
56–67.
Church, R. M., and Broadbent, H. A.
(1990). Alternative representations
of time, number, and rate. Cognition
37, 55–81.
Church, R. M., Meck, W. H., and Gib-
bon, J. (1994). Application of scalar
timing theory to individual trials. J.
Exp. Psychol. Anim. Behav. Process.
20, 135–155.
Coull, J. T., Cheng, R. K., and Meck,
W. H. (2011). Neuroanatomical and
neurochemical substrates of tim-
ing. Neuropsychopharmacology 36,
3–25.
Coull, J. T., Vidal, F., Nazarian, B.,
and Macar, F. (2004). Functional
anatomy of the attentional modula-
tion of time estimation. Science 303,
1506–1508.
Dews, P. B. (1962). The effect of mul-
tiple S delta periods on responding
on a ﬁxed-interval schedule. J. Exp.
Anal. Behav. 5, 369–374.
Gallistel, C. R. (1990). The Organization
of Behavior. Cambridge, MA: MIT
Press.
Gibbon, J. (1977). Scalar expectancy
theory and Weber’s law in ani-
mal timing. Psychol. Rev. 84,
279–325.
Gibbon, J., Church, R. M., and Meck,
W. H. (1984). Scalar timing in mem-
ory. Ann. N. Y. Acad. Sci. 423,
52–77.
Grossberg, S., and Merrill, J. W. (1992).
A neural network model of adap-
tively timed reinforcement learn-
ing and hippocampal dynamics.
Brain Res. Cogn. Brain Res. 1,
3–38.
Grossberg, S., and Schmajuk, N. A.
(1989). Neural dynamics of adaptive
timing and temporal discrimination
during associative learning. Neural
Netw. 2, 79–102.
Harrington, D. L., and Haaland, K. Y.
(1991). Sequencing in Parkinson’s
disease. Abnormalities in program-
ming and controlling movement.
Brain Res. 114, 99–115.
Harrington, D. L., Haaland, K. Y., and
Knight, R. T. (1998). Cortical net-
works underlying mechanisms of
time perception. J. Neurosci. 18,
1085–1095.
Hinton, S. C., and Meck, W. H. (1997).
The ‘internal clocks’ of circadian
and interval timing. Endeavour 21,
3–8.
Houk, J. C. (1995). “Information pro-
cessing in modular circuits linking
basal ganglia and cerebral cortex,” in
Models of Information Processing in
the Basal Ganglia, eds J. C.Houk, J. L.
Davis, and D. G. Beiser (Cambridge:
MIT Press), 3–10.
Houk, J. C., Davis, J. L., and Beiser,D. G.
(1995).Computational Neuroscience,
Models of Information Processing in
the Basal Ganglia. Cambridge: MIT
Press.
Killeen, P. R., and Fetterman, J.
G. (1988). A behavioral the-
ory of timing. Psychol. Rev. 95,
274–295.
Leon, M. I., and Shadlen, M. N. (2003).
Representation of time by neu-
rons in the posterior parietal cor-
tex of the macaque. Neuron 38,
317–327.
Machado, A. (1997). Learning the tem-
poral dynamics of behavior. Psychol.
Rev. 104, 241–265.
Malapani, C., Deweer, B., and Gib-
bon, J. (2002). Separating stor-
age from retrieval dysfunction of
temporal memory in Parkinson’s
disease. J. Cogn. Neurosci. 14,
311–322.
Malapani, C., and Fairhurst, S.
(2002). Scalar timing in animals
and humans. Learn. Motiv. 33,
156–176.
Malapani, C., Rakitin, B., Levy, R.,
Meck, W. H., Deweer, B., Dubois,
B., and Gibbon, J. (1998). Cou-
pled temporal memories in Parkin-
son’s disease: a dopamine-related
dysfunction. J. Cogn. Neurosci. 10,
316–331.
Maricq,A.V., andChurch,R.M. (1983).
The differential effects of haloperi-
dol and methamphetamine on time
estimation in the rat. Psychopharma-
cology (Berl.) 79, 10–15.
Maricq, A. V., Roberts, S., and Church,
R. M. (1981). Methamphetamine
and time estimation. J. Exp. Psy-
chol. Anim. Behav. Process. 7,
18–30.
Matell, M. S., King, G. R., and Meck,W.
H. (2004). Differential modulation
of clock speed by the administra-
tion of intermittent versus contin-
uous cocaine. Behav. Neurosci. 118,
150–156.
Matell, M. S., and Meck, W. H.
(1997). A comparison of the tri-
peak and peak-interval procedure in
rats: equivalency of the clock speed
enhancing effect of methampheta-
mine on interval timing. Abst. Soc.
Neurosci. 23, 1315–1316.
Matell, M. S., and Meck, W. H. (2000).
Neuropsychological mechanisms of
interval timing behavior. Bioessays
22, 94–103.
Matell, M. S., and Meck, W. H. (2004).
Cortico-striatal circuits and inter-
val timing: coincidence detection of
oscillatory processes. Cogn. Brain
Res. 21, 139–170.
Frontiers in Integrative Neuroscience www.frontiersin.org September 2011 | Volume 5 | Article 52 | 10
Oprisan and Buhusi Modeling pharmacology of interval timing
Matell,M. S.,Meck,W.H., andNicolelis,
M. A. (2003). Interval timing and
the encoding of signal duration
by ensembles of cortical and stri-
atal neurons. Behav. Neurosci. 117,
760–773.
Mauk, M. D., and Buonomano, D. V.
(2004). The neural basis of tempo-
ral processing. Annu. Rev. Neurosci.
27, 307–340.
Meck, W. H. (1983). Selective adjust-
ment of the speed of internal
clock and memory processes. J.
Exp. Psychol. Anim. Behav. Process.
171–201.
Meck, W. H. (1996). Neuropharmacol-
ogy of timing and time perception.
Cogn. Brain Res. 3, 227–242.
Meck, W. H. (2006). Neuroanatomical
localization of an internal clock: a
functional link between mesolim-
bic, nigrostriatal, and mesocortical
dopaminergic systems. Brain Res.
1109, 93–107.
Meck, W. H., Cheng, R.-K., Mac-
donald, C. J., Gainetdinov, R. R.,
Caron, M. G., and Çevik, M. N. Ö.
(2011). Gene-dose dependent effects
of methamphetamine on inter-
val timing in dopamine-transporter
knockout mice. Neuropharmacology
doi: 10.1016/j.neuropharm.2011.01.
042. [Epub ahead of print].
Meck, W. H., and Church, R. M.
(1987a). Cholinergic modulation of
the content of temporal memory.
Behav. Neurosci. 101, 457–464.
Meck, W. H., and Church, R. M.
(1987b). Nutrients that modify the
speed of internal clock and memory
storage processes. Behav. Neurosci.
101, 465–475.
Meck, W. H., Church, R. M., Wenk,
G. L., and Olton, D. S. (1987).
Nucleus basalis magnocellularis and
medial septal area lesions differen-
tially impair temporal memory. J.
Neurosci. 7, 3505–3511.
Meck,W. H., Penney, T. B., and Pouthas,
V. (2008). Cortico-striatal repre-
sentation of time in animals and
humans. Curr. Opin. Neurobiol. 18,
145–152.
Miall, R. C. (1989). The storage of time
intervals using oscillating neurons.
Neural Comput. 1, 359–371.
Morris, C., and Lecar, H. (1981). Volt-
age oscillations in the barnacle
giant muscle ﬁber. Biophys. J. 35,
193–213.
Nagelkerke, N. (1991). A note on a
general deﬁnition of the coefﬁcient
of determination. Biometrika 78,
691–692.
Neil, D. B., and Herndon, J. D.
Jr. (1978). Anatomical speciﬁcity
within rat striatum for the dopamin-
ergic modulation of DRL respond-
ing and activity. Brain Res. 153,
529–538.
Olton, D. S., Wenk, G. L., Church,
R. M., and Meck, W. H. (1988).
Attention and the frontal cortex as
examined by simultaneous tempo-
ral processing. Neuropsychologia 26,
307–318.
Onoe, H., Komori, M., Onoe, K.,
Takechi,H.,Tsukada,H., andWatan-
abe, Y. (2001). Cortical networks
recruited for time perception: a
monkey positron emission tomog-
raphy (PET) study. Neuroimage 13,
37–45.
Rakitin, B. C., Gibbon, J., Penney,
T. B., Malapani, C., Hinton, S.
C., and Meck, W. H. (1998).
Scalar expectancy theory and peak-
interval timing in humans. J. Exp.
Psychol. Anim. Behav. Process. 24,
15–33.
Rao, S. M., Mayer, A. R., and Har-
rington, D. L. (2001). The evolu-
tion of brain activation during tem-
poral processing. Nat. Neurosci. 4,
317–323.
Resnick, S. I. (2006). Heavy-Tail Phe-
nomena: Probabilistic and Statistical
Modeling. New York: Springer.
Reutimann, J., Yakovlev, V., Fusi, S., and
Senn,W. (2004). Climbing neuronal
activity as an event-based cortical
representation of time. J. Neurosci.
24, 3295–3303.
Rinzel, J., and Ermentrout, B. (1998).
“Analysis of neural excitability and
oscillations,” in Methods of Neu-
ronal Modeling, eds C. Koch and I.
Segev (Cambridge, MA: MIT Press),
135–169.
Rizzuto, D. S., Madsen, J. R., Brom-
ﬁeld, E. B., Schulze-Bonhage, A.,
Seelig, D., Aschenbrenner-Scheibe,
R., and Kahana, M. J. (2003). Reset
of human neocortical oscillations
during a working memory task.
Proc. Natl. Acad. Sci. U.S.A. 100,
7931–7936.
Schubotz, R. I., Friederici, A. D., and
Yves Von Cramon, D. (2000). Time
perception and motor timing: a
common cortical and subcortical
basis revealed by fMRI. Neuroimage
11, 1–12.
Simen, P., Balci, F., Desouza, L., Cohen,
J. D., andHolmes, P. (2011).Amodel
of interval timing by neural integra-
tion. J. Neurosci. 31, 9238–9253.
Staddon, J. E., and Higa, J. J. (1999).
Time and memory: towards a
pacemaker-free theory of interval
timing. J. Exp. Anal. Behav. 71,
215–251.
Stevens, M. C., Kiehl, K. A., Pearl-
son, G., and Calhoun, V. D. (2007).
Functional neural circuits for men-
tal timekeeping. Hum. Brain Mapp.
28, 394–408.
Swearingen, J. E., and Buhusi, C. V.
(2010). The pattern of responding
in the peak-interval procedure with
gaps: an individual-trials analysis. J.
Exp. Psychol. Anim. Behav. Process.
36, 443–455.
Talton, L. E., Higa, J. J., and Stad-
don, J. E. R. (1999). Interval sched-
ule performance in the goldﬁsh
Carassius auratus. Behav. Process. 45,
193–206.
Conﬂict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
could be construed as a potential con-
ﬂict of interest.
Received: 30 June 2011; paper pend-
ing published: 18 July 2011; accepted:
24 August 2011; published online: 23
September 2011.
Citation: Oprisan SA and Buhusi
CV (2011) Modeling pharmacologi-
cal clock and memory patterns of
interval timing in a striatal beat-
frequency model with realistic, noisy neu-
rons. Front. Integr. Neurosci. 5:52. doi:
10.3389/fnint.2011.00052
Copyright © 2011 Oprisan and Buhusi.
This is an open-access article subject
to a non-exclusive license between the
authors and Frontiers Media SA, which
permits use, distribution and reproduc-
tion in other forums, provided the original
authors and source are credited and other
Frontiers conditions are complied with.
Frontiers in Integrative Neuroscience www.frontiersin.org September 2011 | Volume 5 | Article 52 | 11
